Active Ingredient(s): Tetrabenazine
FDA Approved: * August 15, 2008
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Xenazine Overview

Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off label," tetrabenazine was the first approved treatment for Huntington's disease in the U.S.[3] The compound has been known since the 1950...

Read more Xenazine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tetrabenazine

Recent Xenazine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 12.5mg, 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xenazine: (2 results)

Sorted by National Drug Code
  • 67386-421 Xenazine 12.5 mg Oral Tablet by Lundbeck Inc.
  • 67386-422 Xenazine 25 mg Oral Tablet by Lundbeck Inc.

Other drugs which contain Tetrabenazine or a similar ingredient: (3 results)